36 related articles for article (PubMed ID: 12619635)
1. Advancing concussion research - follow the yellow brick road.
Reinsberger C; Gardner AJ
J Sci Med Sport; 2024 Apr; 27(4):211-212. PubMed ID: 38609281
[No Abstract] [Full Text] [Related]
2. Moving Molecular Oncology Into Community Practice: Follow the Yellow Brick Road.
Raghavan D
JCO Oncol Pract; 2023 Aug; 19(8):528-529. PubMed ID: 37319385
[No Abstract] [Full Text] [Related]
3. Further Along the Yellow Brick Road: Pathway to Progress in Preventing and Treating HDFN.
Fung-Kee-Fung K; Clarke G
J Obstet Gynaecol Can; 2024 Apr; 46(4):102424. PubMed ID: 38697705
[No Abstract] [Full Text] [Related]
4. Putting nature back into drug discovery.
Müller-Kuhrt L
Nat Biotechnol; 2003 Jun; 21(6):602. PubMed ID: 12776140
[No Abstract] [Full Text] [Related]
5. Globalization of quantitative pharmacology: first international symposium of quantitative pharmacology in drug development and regulation.
Barrett JS; Shi J; Xie HT; Huang XH; Fossler MJ; Sun RY
J Clin Pharmacol; 2008 Jul; 48(7):787-92. PubMed ID: 18490494
[TBL] [Abstract][Full Text] [Related]
6. A return to the fundamentals of drug discovery?
Williams M
Curr Opin Investig Drugs; 2004 Jan; 5(1):29-33. PubMed ID: 14983970
[No Abstract] [Full Text] [Related]
7. Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action.
Ganter B; Tugendreich S; Pearson CI; Ayanoglu E; Baumhueter S; Bostian KA; Brady L; Browne LJ; Calvin JT; Day GJ; Breckenridge N; Dunlea S; Eynon BP; Furness LM; Ferng J; Fielden MR; Fujimoto SY; Gong L; Hu C; Idury R; Judo MS; Kolaja KL; Lee MD; McSorley C; Minor JM; Nair RV; Natsoulis G; Nguyen P; Nicholson SM; Pham H; Roter AH; Sun D; Tan S; Thode S; Tolley AM; Vladimirova A; Yang J; Zhou Z; Jarnagin K
J Biotechnol; 2005 Sep; 119(3):219-44. PubMed ID: 16005536
[TBL] [Abstract][Full Text] [Related]
8. Follow the yellow brick road.
Nat Rev Drug Discov; 2003 Mar; 2(3):167. PubMed ID: 12619635
[No Abstract] [Full Text] [Related]
9. Early integration of pharmacokinetic and dynamic reasoning is essential for optimal development of lead compounds: strategic considerations.
Gabrielsson J; Dolgos H; Gillberg PG; Bredberg U; Benthem B; Duker G
Drug Discov Today; 2009 Apr; 14(7-8):358-72. PubMed ID: 19162219
[TBL] [Abstract][Full Text] [Related]
10. Anticipating drug side effects by comparative pharmacology.
Garcia-Serna R; Mestres J
Expert Opin Drug Metab Toxicol; 2010 Oct; 6(10):1253-63. PubMed ID: 20662552
[TBL] [Abstract][Full Text] [Related]
11. Application of pharmaceutical profiling assays for optimization of drug-like properties.
Di L; Kerns EH
Curr Opin Drug Discov Devel; 2005 Jul; 8(4):495-504. PubMed ID: 16022186
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
